Inhaled Iloprost for Suspected COVID-19 Respiratory Failure

NCT04445246 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
ARDS, Human
Hypoxemic Respiratory Failure

Interventions

DRUG: Inhaled ILOPROST

Sponsor

Hamad Medical Corporation